Good prospects for drug/radiation combo

It was a mistery: Why didn't drugs which boost the tumor-killing power of immune cells in lab do well in clincal trials? Now researchers from Rockefeller University describe a way to enhance the ability of these drugs by combining them with radiation therapy.

Drug/radiation combo may help shrink established tumours.
Drug/radiation combo may help shrink established tumours.

The immune system’s tumor-fighting T cells work best when maximally activated. Scientists have achieved this by blocking molecules that dampen the cells’ activation, or by removing a population of regulatory T cells that block killing ability of tumor-specific T cells. But neither approach has worked well in patients with established tumors.

Combining these two approaches, a new study published online on August 25th in the Journal of Experimental Medicine, caused small tumors to shrink but had no effect on large tumors. This finding suggested that some quality of large tumors makes them resistant to T cell killing.

Indeed,  blood vessels around large tumors lacked proteins required for killer T cells to crawl out of the circulation and into the tumor. Combining the T cell-boosting treatment with radiation therapy – which has been shown to increase the expression of these vessel proteins – was effective in shrinking also large tumors. It remains to be seen whether combining radiation therapy with T cell-boosting drugs will be effective in humans.

26.08.2008

Read all latest stories

Related articles

Photo

News • Stem cell regeneration

Drug accelerates recovery after chemo, radiation

A drug developed by US physician-scientists and chemists speeds up the regeneration of mouse and human blood stem cells after exposure to radiation. If the results can be replicated in humans, the…

Photo

Article •

Endovascular brachytherapy

Endovascular brachytherapy has been successfully modified by scientists at Isotopen Technologie München AG (ITM), solving problems of radiation exposure to Rhenium-188. The researchers are now…

Photo

News • Study on meth, cannabis, cocaine and opiate use

Illicit drugs linked with atrial fibrillation

Methamphetamines, cocaine, opiates, and cannabis are associated with an increased likelihood of developing atrial fibrillation, a newly-published 11-year study shows.

Related products

i-Solutions Health – RadCentre Cockpit & Speech Integration

RIS

i-Solutions Health – RadCentre Cockpit & Speech Integration

Mesalvo Mannheim GmbH (ehemals i-SOLUTIONS Health GmbH)
i-Solutions Health – RadCentre Dose View

Dose Management Systems

i-Solutions Health – RadCentre Dose View

Mesalvo Mannheim GmbH (ehemals i-SOLUTIONS Health GmbH)
Noras – Encompass 15-Channel Headcoil

MRI Coils

Noras – Encompass 15-Channel Headcoil

Noras MRI products GmbH
Sarstedt – Low DNA Binding Micro Tubes

Research Use Only

Sarstedt – Low DNA Binding Micro Tubes

SARSTEDT AG & CO. KG
Shimadzu – CLAM-2030 CL (IVD)/ CLAM-2030 (RUO)

Mass Spectrometry

Shimadzu – CLAM-2030 CL (IVD)/ CLAM-2030 (RUO)

Shimadzu Europa GmbH
Subscribe to Newsletter